[1] J. Maiuolo, F. Oppedisano, S. Gratteri, C. Muscoli, and V. Mollace, “Regulation of uric acid metabolism and excretion,” Int. J. Cardiol., vol. 213, pp. 8–14, 2016.
[2] M. Jin et al., “Uric acid, hyperuricemia and vascular diseases,” Front. Biosci. a J. virtual Libr., vol. 17, p. 656, 2012.
[3] A. Sidari and E. Hill, “Diagnosis and treatment of gout and pseudogout for everyday practice,” Prim. Care Clin. Off. Pract., vol. 45, no. 2, pp. 213–236, 2018.
[4] C.-F. Kuo, M. J. Grainge, W. Zhang, and M. Doherty, “Global epidemiology of gout: prevalence, incidence and risk factors,” Nat. Rev. Rheumatol., vol. 11, no. 11, pp. 649–662, 2015.
[5] J. A. Singh, “Racial and gender disparities among patients with gout,” Curr. Rheumatol. Rep., vol. 15, no. 2, p. 307, 2013.
[6] J. H. Jung et al., “Metabolic syndrome: prevalence and risk factors in Korean gout patients,” Korean J. Intern. Med., vol. 33, no. 4, p. 815, 2018.
[7] H. K. Choi, L. C. Soriano, Y. Zhang, and L. A. G. Rodríguez, “Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study,” Bmj, vol. 344, 2012.
[8] C.-F. Kuo et al., “Familial aggregation of gout and relative genetic and environmental contributions: a nationwide population study in Taiwan,” Ann. Rheum. Dis., vol. 74, no. 2, pp. 369–374, 2015.
[9] S. P. Juraschek, A. C. Gelber, H. K. Choi, L. J. Appel, and E. R. Miller III, “Effects of the Dietary Approaches to Stop Hypertension (DASH) diet and sodium intake on serum uric acid,” Arthritis Rheumatol., vol. 68, no. 12, pp. 3002–3009, 2016.
[10] S. K. Rai, T. T. Fung, N. Lu, S. F. Keller, G. C. Curhan, and H. K. Choi, “The Dietary Approaches to Stop Hypertension (DASH) diet, Western diet, and risk of gout in men: prospective cohort study,” bmj, vol. 357, 2017.
[11] S. J. Lee et al., “Perceptions of disease and health-related quality of life among patients with gout,” Rheumatology, vol. 48, no. 5, pp. 582–586, 2009.
[12] N. Martini et al., “Living with gout in New Zealand: an exploratory study into people’s knowledge about the disease and its treatment,” JCR J. Clin. Rheumatol., vol. 18, no. 3, pp. 125–129, 2012.
[13] A. A. Atalla, M. G. Albuqami, M. A. Albogami, A. K. Alharthi, and T. D. Altowairqi, “Awareness of gout disease among adult population in Taif city,” Int. J. Med. Dev. Ctries., vol. 4, no. 2, pp. 365–369, 2020.
[14] Y. Zhu, B. J. Pandya, and H. K. Choi, “Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007–2008,” Arthritis Rheum., vol. 63, no. 10, pp. 3136–3141, 2011.
[15] M. Kuwabara, “Hyperuricemia, cardiovascular disease, and hypertension,” Pulse, vol. 3, no. 3–4, pp. 242–252, 2015.
[16] L. Bai, J.-B. Zhou, T. Zhou, R. B. Newson, and M. A. Cardoso, “Incident gout and weight change patterns: a retrospective cohort study of US adults,” Arthritis Res. Ther., vol. 23, no. 1, pp. 1–9, 2021.
[17] Y. Zhang et al., “Purine-rich foods intake and recurrent gout attacks,” Ann. Rheum. Dis., vol. 71, no. 9, pp. 1448–1453, 2012.
[18] M. Kakutani-Hatayama et al., “Nonpharmacological management of gout and hyperuricemia: hints for better lifestyle,” Am. J. Lifestyle Med., vol. 11, no. 4, pp. 321–329, 2017.
[19] I. M. M. Alshammari and M. A. Mujtaba, “Public Knowledge and Awareness about Gout: A Cross-sectional Study in Qatar,” J. Pharm. Res. Int., pp. 1–11, 2017.
[20] T. Neogi, C. Chen, J. Niu, C. Chaisson, D. J. Hunter, and Y. Zhang, “Alcohol quantity and type on risk of recurrent gout attacks: an internet-based case-crossover study,” Am. J. Med., vol. 127, no. 4, pp. 311–318, 2014.
[21] T. Sugie, T. Imatou, M. Miyazaki, and H. Une, “The effect of alcoholic beverage type on hyperuricemia in Japanese male office workers,” J. Epidemiol., vol. 15, no. 2, pp. 41–47, 2005.
[22] B. Spaetgens, T. Pustjens, L. E. J. M. Scheepers, H. J. E. M. Janssens, S. van der Linden, and A. Boonen, “Knowledge, illness perceptions and stated clinical practice behaviour in management of gout: a mixed methods study in general practice,” Clin. Rheumatol., vol. 35, no. 8, pp. 2053–2061, 2016.
[23] C. Ben Salem, R. Slim, N. Fathallah, and H. Hmouda, “Drug-induced hyperuricaemia and gout,” Rheumatology, vol. 56, no. 5, pp. 679–688, 2017.
[24] A. J. Landgren et al., “Incidence of and risk factors for nephrolithiasis in patients with gout and the general population, a cohort study,” Arthritis Res. Ther., vol. 19, no. 1, pp. 1–9, 2017.
[25] A. NGAYIMBESHA, J. B. BIZIMANA, and M. S. GAKIMA, “Burundi Population Awareness about Gout and the Pivotal Role Played by Physical Exercise in Prevent and Managing Gout Relating Prob-lems,” Int J Sport. Exerc Med, vol. 5, p. 139, 2019.
[26] L. R. Harrold, K. M. Mazor, D. Peterson, N. Naz, C. Firneno, and R. A. Yood, “Patients’ knowledge and beliefs concerning gout and its treatment: a population based study,” BMC Musculoskelet. Disord., vol. 13, no. 1, pp. 1–8, 2012.